| abstract |
Anticholinergic agents of formula (1) are disclosed, in which X¯ and the groups A, B, R, R1, R2, R3, R3', R4, R4', Rx and Rx' are as defined in the specification. A method for producing said anticholinergic agents and to the use thereof as medicaments for the treatment of asthma, COPD, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal tract, spasms in the urinary tract and menstrual pain is also disclosed. |